Purification and characterization of recombinant human interleukin-29 expressed in Escherichia coli

Journal of Biotechnology

Volumn 122, Issue 3, 2006, Pages 334-340

  Li, Mingcai ^a   He, Shaoheng ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Interleukin 29; Purification; Recombinant; S tag fusion protein

Indexed keywords

AFFINITY CHROMATOGRAPHY; CELL CULTURE; ESCHERICHIA COLI; PROTEINS;

CYTOKINES; INTERLEUKIN-29; RECOMBINANT; S-TAG FUSION PROTEIN;

GENETIC ENGINEERING;

CYTOKINE; HYBRID PROTEIN; THROMBIN;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PURIFICATION;

CELL LINE; CYTOKINES; ESCHERICHIA COLI; GENETIC VECTORS; HUMANS; INTERLEUKINS; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; THROMBIN; VESICULAR STOMATITIS-INDIANA VIRUS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33644653170     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2005.11.019     Document Type: Article

References (24)

1. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res. 25 1997 3389 3402
2. C. Aslanidis, and P.J. de Jong Ligation-independent cloning of PCR products (LIC-PCR) Nucleic Acids Res. 18 1990 6069 6074
3. L.S. Belkowski, and G.C. Sen Inhibition of vesicular stomatitis viral mRNA synthesis by interferons J. Virol. 61 1987 653 660
4. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. S. Brand, K. Zitzmann, J. Dambacher, F. Beigel, T. Olszak, G. Vlotides, S.T. Eichhorst, B. Goke, H. Diepolder, and C.J. Auernhammer SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29 Biochem. Biophys. Res. Commun. 331 2005 543 548
6. E.M. Coccia, M. Severa, E. Giacomini, D. Monneron, M.E. Remoli, I. Julkunen, M. Cella, R. Lande, and G. Uze Viral infection and Toll-like receptor agonists induce a differential expression of type I and (interferon as in human plasmacytoid and monocyte-derived dendritic cells Eur. J. Immunol. 34 2004 796 805
7. G.D. Davis, C. Elisee, D.M. Newham, and R.G. Harrison New fusion protein systems designed to give soluble expression in Escherichia coli Biotechnol. Bioeng. 65 1999 382 388
8. L. Dumoutier, A. Tounsi, T. Michiels, C. Sommereyns, S.V. Kotenko, and J.C. Renauld Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signalling J. Biol. Chem. 279 2004 32269 32274
9. P.C. Familletti, S. Rubinstein, and S. Pestka A convenient and rapid cytopathic effect inhibition assay for interferon Methods Enzymol. 78 1981 387 394
10. G. Gautier, M. Humbert, F. Deauvieau, M. Scuiller, J. Hiscott, E.E. Bates, G. Trinchieri, C. Caux, and P. Garrone A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells J. Exp. Med. 201 2005 1435 1446
11. R.S. Haun, I.M. Serventi, and J. Moss Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors Biotechniques 13 1992 515 518
12. I.C. Ho, M.R. Hodge, J.W. Rooney, and L.H. Glimcher The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4 Cell 85 1996 973 983
13. J.S. Kim, and R.T. Raines Ribonuclease S-peptide as a carrier in fusion proteins Protein Sci. 2 1993 348 356
14. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, N.K. Shah, J.A. Langer, F. Sheikh, H. Dickensheets, and R.P. Donnelly IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex Nat. Immunol. 4 2003 69 77
15. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
16. J.K. Langer, E.C. Cutrone, and S.V. Kotenko The class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions Cytokine Growth Factor Rev. 15 2004 33 48
17. M. Li, and S. He IL-10 and its related cytokines for treatment of inflammatory bowel disease World J. Gastroenterol. 10 2004 620 625
18. A. Meager, K. Visvalingam, P. Dilger, D. Bryan, and M. Wadhwa Biological activity of interleukins-28 and -29: comparison with type I interferons Cytokine 31 2005 109 118
19. S. Pestka, C.D. Krause, D. Sarkar, M.R. Walter, Y. Shi, and P.B. Fisher Interleukin-10 and related cytokines and receptors Annu. Rev. Immunol. 22 2004 929 979
20. J.C. Renauld Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators Nat. Rev. Immunol. 3 2003 667 676
21. M.D. Robek, B.S. Boyd, and F.V. Chisari Lambda interferon inhibits hepatitis B and C virus replication J. Virol. 79 2005 3851 3854
22. C.H. Schein Solubility and secretability Curr. Opin. Biotechnol. 4 1993 456 461
23. P. Sheppard, W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, T.E. Whitmore, R. Kuestner, U. Garrigues, C. Birks, J. Roraback, C. Ostrander, D. Dong, J. Shin, S. Presnell, B. Fox, B. Haldeman, E. Cooper, D. Taft, T. Gilbert, F.J. Grant, M. Tackett, W. Krivan, G. McKnight, C. Clegg, D. Foster, and K.M. Klucher IL-28, IL-29 and their class II cytokine receptor IL-28R Nat. Immunol. 4 2003 63 68
24. J. Siren, J. Pirhonen, I. Julkunen, and S. Matikainen IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29 J. Immunol. 174 2005 1932 1937